e-learning
resources
Virtual 2021
06.09.2021
Lung disease burden and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of chronic obstructive pulmonary diseases with acute exacerbation and its associated factors treated by out-of-hospital emergencies in Madrid
A. CINTORA (AMADRIDlcobendas, Spain), C. Horrillo (Alcobendas, Spain), A. Gutierrez (Alcobendas, Spain), E. Robledi (Alcobendas, Spain), A. Perez (Alcobendas, Spain)
Source:
Virtual Congress 2021 – Lung disease burden and management
Session:
Lung disease burden and management
Session type:
E-poster
Number:
2154
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. CINTORA (AMADRIDlcobendas, Spain), C. Horrillo (Alcobendas, Spain), A. Gutierrez (Alcobendas, Spain), E. Robledi (Alcobendas, Spain), A. Perez (Alcobendas, Spain). Prevalence of chronic obstructive pulmonary diseases with acute exacerbation and its associated factors treated by out-of-hospital emergencies in Madrid. 2154
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Prevalence of chronic obstructive pulmonary diseases related-hospitalization with acute exacerbation and its associated factors in Thailand.
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
Hyperglycaemia and its association with outcomes in people admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 332s
Year: 2006
Readmission predictors in patients with chronic obstructive pulmonary disease hospitalized for an exacerbation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011
Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Predictors of mortality after hospitalisation for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011
Causes of acute exacerbation of chronic obstructive pulmonary disease (COPD) in a hospital in Bucharest
Source: Eur Respir J 2003; 22: Suppl. 45, 240s
Year: 2003
Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Bacterial profile of acute infectious exacerbations of chronic obstructive pulmonary disease requiring hospitalization in Greece
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Readmissions after hospitalization for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Factors affecting in-hospital mortality in patients with chronic obstructive pulmonary disease exacerbation
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013
Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment
Year: 2008
Acute coronary events during acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation
Year: 2010
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Costs of the patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease in a tertiary university hospital of Turkey
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003
Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept